Press Releases

Date Title and Summary Additional Formats
Toggle Summary Harvard Bioscience Reports First Quarter 2016 Financial Results
Conference Call To Be Held at 8:30 AM ET Today
View HTML
Toggle Summary Harvard Bioscience Regains Compliance with NASDAQ's Continued Listing Requirements
HOLLISTON, Mass., May 04, 2016 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO) (the "Company"), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, announced today that it received written notification from NASDAQ (the "Notice") stating
View HTML
Toggle Summary Harvard Bioscience Reports Fourth Quarter and Year-End 2015 Results, Preliminary First Quarter 2016 Revenues and 2016 Financial Guidance
Reports Results of Embezzlement Investigation Conference Call to Discuss 2015 and First Quarter 2016 Results to be Held on May 12, 2016 at 8:30 AM ET HOLLISTON, Mass., April 29, 2016 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO) (the "Company"), a global developer, manufacturer and
View HTML
Toggle Summary Harvard Bioscience Delays Filing of Annual Report on Form 10-K and Announces Preliminary Unaudited Fourth Quarter and Fiscal Year 2015 Revenue
HOLLISTON, Mass., March 28, 2016 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO) (the "Company"), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, today announced that the filing of its Annual Report on Form 10-K for the year ended
View HTML
Toggle Summary Harvard Bioscience Receives NASDAQ Delinquency Notice
HOLLISTON, Mass., March 17, 2016 (GLOBE NEWSWIRE) -- On March 16, 2016, Harvard Bioscience, Inc. (Nasdaq:HBIO) (the "Company"), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, received a notice from NASDAQ (the "Notice") stating the Company is
View HTML
Toggle Summary Harvard Bioscience Announces Delay in Filing Form 10-K
Reports Delay is Result of Forensic Investigation Following Minor Employee Theft Will schedule conference call to discuss fourth quarter and full year 2015 results upon completion of the investigation HOLLISTON, Mass., March 14, 2016 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc.
View HTML
Toggle Summary Harvard Bioscience Reports Third Quarter 2015 Financial Results and Updates Outlook for Full-Year 2015
Conference Call to be Held at 8:30 AM ET Today
View HTML
Toggle Summary Harvard Bioscience to Showcase Array of New Products at Society for Neuroscience 2015 Annual Meeting in Chicago on October 18-21
Three Symposium Events Highlight Newest Electrophysiology Research Tools
View HTML
Toggle Summary Harvard Bioscience Schedules Third Quarter 2015 Conference Call for October 29 at 8:30 AM ET
HOLLISTON, Mass., Oct. 15, 2015 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, will announce results for its third quarter 2015 before market trading hours on Thursday, October 29,
View HTML
Toggle Summary Harvard Bioscience Q2 2015 Revenues Increase 7% Year-over-Year, 12% in Constant Currency, to $28.8 Million
-Conference Call To Be Held at 8:30 AM ET Today- HOLLISTON, Mass., July 30, 2015 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, today reported financial highlights for the three and six
View HTML